His scientific interests lie mostly in Cell biology, Molecular biology, Tumor necrosis factor alpha, Receptor and Lymphotoxin beta receptor. His work deals with themes such as Immunology, Immune system, Lymphotoxin and Programmed cell death, which intersect with Cell biology. His Molecular biology study incorporates themes from NFKB1, T cell, Cytotoxic T cell and Cell culture.
Carl F. Ware combines subjects such as Cell and Cytokine with his study of Tumor necrosis factor alpha. His Receptor research incorporates themes from B-cell activating factor and MAPK/ERK pathway. His work carried out in the field of Lymphotoxin beta receptor brings together such families of science as Central tolerance, Autoimmunity, Autoimmune regulator, Lymphotoxin alpha and Fusion protein.
His primary areas of study are Cell biology, Immunology, Tumor necrosis factor alpha, Receptor and Lymphotoxin. His Signal transduction and Effector study in the realm of Cell biology connects with subjects such as Herpesvirus entry mediator. His work in Immunology covers topics such as Cytotoxic T cell which are related to areas like CD8, Antigen and Lymphokine.
His biological study spans a wide range of topics, including Cell, Cancer research, Cytokine, Inflammation and Apoptosis. Receptor is closely attributed to Molecular biology in his study. His Lymphotoxin research is multidisciplinary, incorporating elements of Stromal cell and Lymphatic system.
Carl F. Ware spends much of his time researching Immune system, Cell biology, Immunology, Tumor necrosis factor alpha and Cancer research. The various areas that Carl F. Ware examines in his Immune system study include Antibody, B cell, Antigen and Cytokine. The Cell biology study combines topics in areas such as BTLA and Innate lymphoid cell.
His study in Lymphotoxin, Lymphotoxin beta receptor, Inflammation, Lymphotoxin beta and Autoimmunity falls under the purview of Immunology. His Tumor necrosis factor alpha research integrates issues from Cytotoxic T cell, Receptor and Immunotherapy. Carl F. Ware interconnects CCL5, Chemokine, Bone metastasis, Lung cancer and Programmed cell death in the investigation of issues within Cancer research.
Carl F. Ware mainly investigates Immunology, Cell biology, Immune system, Cancer research and T cell. Lymphotoxin beta receptor, Lymphotoxin beta, Lymphotoxin, Interferon type I and Spleen are subfields of Immunology in which his conducts study. Carl F. Ware is studying Signal transduction, which is a component of Cell biology.
The study of Immune system is intertwined with the study of Tumor necrosis factor alpha in a number of ways. His Cancer research study integrates concerns from other disciplines, such as Fibrosis, Chemokine, Programmed cell death and Tumor initiation. He has researched T cell in several fields, including Tumor microenvironment, FOXP3 and High endothelial venules.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
Thomas Brunner;Rona J. Mogil;Drake LaFace;Nam Jin Yoo.
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
George Mosialos;Mark Birkenbacht;Ramana Yalamanchill;Todd Van Arsdale.
The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways
Emmanuel Dejardin;Nathalie M Droin;Mireille Delhase;Elvira Haas.
Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.
Francisco Sanchez-Madrid;Alan M. Krensky;Carl F. Ware;Elizabeth Robbins.
Proceedings of the National Academy of Sciences of the United States of America (1982)
LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator
Davide N Mauri;Reinhard Ebner;Rebecca I Montgomery;Kristine D Kochel.
Rapid colormetric assay for cell viability: Application to the quantitation of cytotoxic and growth inhibitory lymphokines
Lora M. Green;Jeanne L. Reade;Carl F. Ware.
Journal of Immunological Methods (1984)
Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface
Jeffrey L. Browning;Apinya Ngam-ek;Pornsri Lawton;Janice DeMarinis.
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
John R Sedy;Maya Gavrieli;Karen G Potter;Michelle A Hurchla.
Nature Immunology (2005)
Regulated Expression of Nuclear Receptor RORγt Confers Distinct Functional Fates to NK Cell Receptor-Expressing RORγt+ Innate Lymphocytes
Cedric Vonarbourg;Arthur Mortha;Viet L. Bui;Viet L. Bui;Pedro P. Hernandez;Pedro P. Hernandez.
NETWORK COMMUNICATIONS: Lymphotoxins, LIGHT, and TNF
Carl F. Ware.
Annual Review of Immunology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: